Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data | |
Yao, Yang; Qi, Wei-Xiang; Wang, Qiong; Jiang, Yan-Ling; Sun, Yuan-Jue; Tang, Li-na; He, Ai-na; Min, Da-liu; Lin, Feng; Shen, Zan | |
刊名 | PLOS ONE
![]() |
2013 | |
卷号 | 8期号:2 |
ISSN号 | 1932-6203 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3448542 |
专题 | 昆明医科大学 |
推荐引用方式 GB/T 7714 | Yao, Yang,Qi, Wei-Xiang,Wang, Qiong,et al. Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data[J]. PLOS ONE,2013,8(2). |
APA | Yao, Yang.,Qi, Wei-Xiang.,Wang, Qiong.,Jiang, Yan-Ling.,Sun, Yuan-Jue.,...&Shen, Zan.(2013).Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data.PLOS ONE,8(2). |
MLA | Yao, Yang,et al."Overall Survival Benefits for Combining Targeted Therapy as Second-Line Treatment for Advanced Non-Small-Cell-Lung Cancer: A Meta-Analysis of Published Data".PLOS ONE 8.2(2013). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论